Shingles drug thumbs up is boost for GSK 

Shingrix is seen as a potential blockbuster by the pharmaceuticals giant. It prevents shingles in adults aged 50 and over, with tests finding it is more effective than existing products on the market.
Source: Top Money Stories

Leave a Reply